(Q40683939)

22 September 2017

title

Comparative safety and efficacy of two immune globulin products in Kawasaki disease (English)

1 reference

22 September 2017

Rosenfeld EA

1

1 reference

22 September 2017

Shulman ST

2

1 reference

22 September 2017

Corydon KE

3

1 reference

22 September 2017

Mason W

4

1 reference

22 September 2017

Takahashi M

5

1 reference

22 September 2017

Kuroda C

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

The Journal of Pediatrics

22 September 2017

published in

1 reference

22 September 2017

volume

126

1 reference

22 September 2017

issue

6

1 reference

22 September 2017

page(s)

1000-1003

1 reference

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970233-4

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970233-4

Immunoglobulin preparations for intravenous administration. A review of their biologic activities and comparison of various preparation methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970233-4

Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970233-4

10.1016/S0022-3476(95)70233-4

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference